ResearchMoz

Eurocine Vaccines AB - Product Pipeline Review - 2012

Global Markets Direct
Published Date » 2012-09-25
No. Of Pages » 23
     
  Eurocine Vaccines AB Product Pipeline Review 2012  
   
 Global Market Directs pharmaceuticals report, Eurocine Vaccines AB Product Pipeline Review 2012 provides data on the Eurocine Vaccines ABs research and development focus. The report includes information on current developmental pipeline, complete with latest updates, and features on discontinued and dormant projects.  
   
 This report is built using data and information sourced from Global Markets Directs proprietary databases, Eurocine Vaccines ABs corporate website, SEC filings, investor presentations and featured press releases, both from Eurocine Vaccines AB and industry-specific third party sources, put together by Global Markets Directs team.  
   
  Scope  
   
 
 
 Eurocine Vaccines AB Brief...
Table of Contents

Table of Contents 2

List of Tables 3
List of Figures 3
Eurocine Vaccines AB Snapshot 4
Eurocine Vaccines AB Overview 4
Key Information 4
Key Facts 4
Eurocine Vaccines AB Research and Development Overview 5
Key Therapeutic Areas 5
Eurocine Vaccines AB Pipeline Review 7
Pipeline Products by Stage of Development 7
Pipeline Products Monotherapy 8
Eurocine Vaccines AB Pipeline Products Glance 9
Eurocine Vaccines AB Clinical Stage Pipeline Products 9
Phase I Products/Combination Treatment Modalities 9
Eurocine Vaccines AB Early Stage Pipeline Products 10
Pre-Clinical Products/Combination Treatment Modalities 10
Eurocine Vaccines AB Drug Profiles 11
Immunose FLU 11
Product Description 11
Mechanism of Action 11
R&D Progress 11
Nasal Pneumococcal Vaccine 13
Product Description 13
Mechanism of Action 13
R&D Progress 13
Eurocine Vaccines AB Pipeline Products by Route of Administration 14
Eurocine Vaccines AB Recent Pipeline Updates 15
Eurocine Vaccines AB Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Eurocine Vaccines AB, Recent Developments 17
Eurocine Vaccines AB- Press Release 17
Jan 04, 2012: Eurocine Vaccines, Bionor Pharma And Oslo University Announce Full Enrollment Of Nasal Immunization Study Of Vacc4x And Endocine 17
Dec 03, 2009: Eurocine Vaccines Clinical Trial Fully Recruited 17
Oct 07, 2009: Eurocine Vaccines Begins Nasal Influenza Vaccine Study In Humans 18
Financial Deals Landscape 19
Eurocine Vaccines AB, Deals Summary 19
Eurocine Vaccines AB, Pharmaceuticals & Healthcare, Deal Details 20
Partnerships 20
Eurocine Vaccines Enters Into Collaboration With HeliCure 20
Equity Offering 21
Eurocine Vaccines Completes Private Placement Of Shares For $1.8 Million 21

Appendix 22
Methodology 22
Coverage 22
Secondary Research 22
Primary Research 22
Expert Panel Validation 22
Contact Us 23
Disclaimer 23

List of Tables


Eurocine Vaccines AB, Key Information 4
Eurocine Vaccines AB, Key Facts 4
Eurocine Vaccines AB Pipeline by Indication, 2012 6
Eurocine Vaccines AB Pipeline by Stage of Development, 2012 7
Eurocine Vaccines AB Monotherapy Products in Pipeline, 2012 8
Eurocine Vaccines AB Phase I, 2012 9
Eurocine Vaccines AB Pre-Clinical, 2012 10
Eurocine Vaccines AB Pipeline By Route of Administration, 2012 14
Eurocine Vaccines AB Recent Pipeline Updates, 2012 15
Eurocine Vaccines AB, Subsidiaries 16
Eurocine Vaccines AB, Deals Summary 19
Eurocine Vaccines Enters Into Collaboration With HeliCure 20
Eurocine Vaccines Completes Private Placement Of Shares For $1.8 Million 21

List of Figures


Eurocine Vaccines AB Pipeline by Indication, 2012 6
Eurocine Vaccines AB Pipeline by Stage of Development, 2012 7
Eurocine Vaccines AB Monotherapy Products in Pipeline, 2012 8

Upcoming Reports:

Dental Diagnostic Equipment Market - Global Industry Size, Market Share, Trends, Analysis And Forecasts 2012 - 2018
By - Transparency Market Research
The market for dental diagnostic equipments consists of devices used in the diagnosis of dental diseases and conditions, so as to enable proper treatment planning. These include intraoral and extraoral radiology equipments and scanners.  Consumption of unhealthy food and improper eating habits has led to an increased incidence of oral diseases worldwide. A growing consumer base opting for dental treatments accompanied by a rise in the number of dental clinics providing such treatment, fuels continuous market growth for this segment. Patients demand painless diagnosis...
Polyester Staple Fiber (PSF) Market - Global Industry Analysis, Size, Share, Growth, Trends And Forecast 2014 - 2020
By - Transparency Market Research
Polyethylene terephthalate (PET), when used in the form of fibers and filaments, is known as polyester. Purified terephthalic acid (PTA) and monoethylene glycol (MEG) are the primary raw materials used in the manufacture of polyester fiber. Polyesters are made by polymerization of purified terephthalic acid (PTA) and monoethylene glycol (MEG). The polymer thus obtained is melt spun to form tow which is a bundle of continuous filaments. The tow is subjected to further processes such as drawing, crimping, spin finish application and then cut into fixed lengths to get cut fibers almost equal...
Global Opportunity in Carbon Capturing & Storage Technology Market (2011 - 2016)
By - Transparency Market Research
  The report contains an elaborative description of the Global Carbon Capture and Storage technology market. The report casts various developments and plans in respective field across the geographies along with the influential factors for this market. It provides the current market scenario and future market forecasts for major markets. The report provides a deep insight to the initiatives taken by governments across the globe which is one of the major driving forces for this market. The major players in this global technology market have been covered as company...

Research Assistance

We will be happy to help you find what you need.
Please call us or write us:

866-997-4948 (Us-Canada Toll Free)
Tel: +1-518-618-1030
Email: sales@researchmoz.us
Select License type:

Share this report

Related News

Order cancellations not a sign of market slump: Airbus
Jul 31, 2014  
Leading aircraft manufacturer Airbus on Wednesday said that the recent wave of order cancellations for its commercial jetliners do not mean that the market has declined. The market is still strong and single-aisle jets deals are likely to return later. A total of 225 Airbus cancellations were reported since the beginning of this year. Of these, Dubai’s Emirates Airlines alone...
Leading Australian Universities Want to Hike Fees, Enroll Fewer Students
Jul 31, 2014  
Australia’s prestigious group of top eight universities, also known as the Group of Eight (Go8), has indicated plans of increasing tuition fees while reducing the number of students they enroll, a reform-backer has predicted. These decisions could be made if the universities are deregulated .  Arguing for this decision, the chairman of Go8, and vice chancellor of the ANU, Ian...
Blackstone Invests $800 Million in Asian Oil-Based Energy Company
Jul 31, 2014  
Blackstone Energy Partners announced to invest $800 million in an Asian based energy company that is led by former industry executives.  Blackstone is popularly considered a part of the world’s largest administrator of alternatives to financial stocks and bonds. New York-based managing director, Angelo Acconcia of Blackstone Energy Partners said in an interview that Tamarind...
Bristol-Myers Squibb Posts USD 3.9 billion Revenues in 2014 Second Quarter
Jul 30, 2014  
Leading bio-pharmaceutical company Bristol-Myers Squibb has registered revenues of USD 3.9 billion in the 2014 second quarter. This marks a 4% decrease from the same period in 2013. The global revenues of the company (excluding the divested Diabetes Alliance), saw a 7% increase. In this quarter, the company’s results were underlined by steady global sales of nearly each of its...
Novartiss Simbrinza gets approval from the EU
Jul 30, 2014  
Glaucoma patients in Europe can easily obtain Novartis’ Simbrinza eye drops which are a combination of brimonidine tartrate and brinzolamide and it is without a beta-blocker. This eye drop has got the approval of the European Commission. Unlike the inefficient treatment provided by monotherapy, this eye drop aims at treating intraocular pressure or IOP in adults with ocular hypertension...